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Abstract
Background To review our experience with morphological
developments during the long-term follow-up of patients treat-
ed by Gamma Knife radiosurgery for mesial temporal lobe
epilepsy.
Method Between 1995 and 1999, we treated 14 patients with
marginal doses of 24 Gy (n=6) and 18–20 Gy (n=8). Nine of
these were operated on for insufficient seizure control. We
reviewed seizure outcome and magnetic resonance images in
both operated and unoperated patients and also re-examined
histopathology specimens.
Results Of the nine operated patients, two were Engel IIIA,
one was IVA, five were IVB, and one was Engel IVC prior to
surgery. At their final visit, five cases had become Engel class
IA, one patient was ID, and two were IIC. In one patient the
follow-up was not long enough for classification. Of the five
unoperated patients, one was Engel class IB, one was IIIA,
one IIB and one IVB at their final visit. Radionecrosis devel-
oped in 11 patients, occurring more often and earlier in those
treated with higher doses. Collateral edema reached outside
the temporal lobe in six patients, caused uncal herniation in
two and intracranial hypertension in three. During longer fol-
low-up, postnecrotic pseudocysts developed in 9 patients, and
postcontrast enhancement persisted for 2.5–16 years after
GKRS in all 14 patients. In five of them we detected its pro-
gression between 2 and 16 years after treatment. Signs of
neoangiogenesis were found in two patients and microbleeds
could be seen in five. Histopathology revealed blood vessel
proliferation and macrophage infiltration.
Conclusions Early delayed complications and morphological
signs suggesting a risk of development of late delayed com-
plications are frequent after radiosurgery for mesial temporal
lobe epilepsy. Together with its unproven antiseizure efficacy,
these issues should be taken into account when planning fu-
ture studies of this method.
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Introduction
Mesial temporal lobe epilepsy (MTLE) with hippocampal
sclerosis (HS) is the most common epilepsy syndrome in
adults and is often associated with pharmacoresistance [31].
In these cases, epilepsy surgery is an effective treatment op-
tion, and patients have a 60–80 % chance of a seizure-free
outcome [8]. However, procedure-related complications are
not negligible [14].
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The need to minimize complication rates and potentially to
improve neuropsychological outcomes provides an impetus
for the development of innovative treatments. Gamma Knife
radiosurgery (GKRS) for MTLE is an extremely attractive
treatment modality.
There are three lines of evidence that GKRSmight work in
MTLE:
1. Experiments on animals with limbic epilepsy produced
significant reductions in both the frequency and duration
of seizures [5]. Animal and human data suggest that
GKRS may have anticonvulsive effects in subnecrotic
do s e s [ 38 ] . P r opo s ed mechan i sms i n c l ud e
neuromodulatory effects on different enzymes and sec-
ondly on amino acids and the selective modification of
the function of epileptic neurons [26]. However, a rela-
tionship was found in animal models between increasing
the radiosurgical dose and the decreasing frequency of
seizures [23]. On the other hand, doses higher than
50 Gy caused edema and necrosis [19].
2. The antiepileptic effectiveness of GKRS in patients with
symptomatic epi lepsies due to ar ter iovenous
malformations (AVM), brain tumors, cavernomas and hy-
pothalamic hamartomas [22]. In epilepsies associated
with AVM, improved control of seizures is significantly
more likely with complete AVM obliteration (82 % and
41 % seizure-free, respectively) [20]. Studies on tumors
indicate that temporal localization and larger doses of ra-
diation outside the lesion border are associated with a
favorable outcome [28].
3. Attempts at radiosurgical interventions indicated for pri-
marily epileptological reasons performed by interstitial
brachytherapy [34], radiotherapy by cobalt irradiator [2]
and fractionated radiotherapy [33].
In 1995, Régis et al. reported preliminary results from the 16-
month follow-up of the first patient treated for MTLE/HS [25].
He had been seizure free since the procedure, and neuroimaging
showed selective injury to the amygdaloentorhinohippocampal
target.
Since then three things have become apparent:
1. Seizure control rates reported from different centers vary.
Favorable seizure outcome comparable to open surgery
has been reported by some authors with 65–67 % of
seizure-free patients [3]. In patients treated with higher
doses, the proportion of seizure-free patients reported
was even higher (76.9 %) [1]. The seizure remission rate
was lower in other studies (0–37.5 %) [32, 37, 18, 6],
some of which used similar treatment parameters to more
successful studies, so the reason for these discrepancies is
not clear. The rate of neurological complications (e.g.,
visual field defects) was probably comparable to open
surgery [15], while the benefit in the neuropsychological
domain was questionable [21].
2. Although GKRS is generally considered a safe treatment
modality, complications after treatment are documented
[10]. They can be classified as early and late. Early com-
plications occur months after treatment and include
radiation-induced edema, which may be associated with
seizure worsening and focal neurological deficits (e.g.,
verbal memory decline) [11]. In approximately 15 % of
patients, edema causes signs of intracranial hypertension
and requires corticosteroid therapy. Delayed seizure con-
trol might pose a heightened risk of sudden unexplained
death. Late complications appear years after treatment and
consist of delayed radionecrosis and cyst formation.
Worsening and de novo development of seizures, intrac-
table epilepsy and HS have been described [16]. Further-
more, seizure relapse was reported in all seizure-free pa-
tients during attempts at drug reduction [1].
3. GKRS has become a treatment option in focal lesions that
are otherwise difficult to access through open surgery
(e.g., hypothalamic hamartomas) [12]. However, seizure
freedom was lower (~30 %) compared to open surgery
(~50%). In the treatment ofMTLE, GKRS has not gained
widespread acceptance [29].
The aim of this study is to review our experience with
development of morphology during long-term follow-up of
patients treated by GKRS for MTLE.
Materials and methods
Patients
Between November 1995 and May 1999, we diagnosed 14
consecutive patients with MTLE/HS and treated them with
GKRS (Supplementary material, Table 1). We described our
group’s characteristics, the presurgical evaluation protocol
and seizure outcome in our previous article [37]. To briefly
recapitulate, there were eight female and six male patients in
whom epilepsy began at a mean age of 10.9 years (2.5–
38 years) and whose mean age at the time of treatment was
33.4 years. By the time GKRS was performed, the patients
had had epilepsy for an average of 23.2 years (9–46). Early
risk factors were present in 12 patients. These were mostly
febrile seizures; one patient (patient 1) had a history of puru-
lent meningitis, and the other (patient 6) had experienced re-
peated afebrile generalized seizures since an early age. All the
patients had complex partial seizures (CPSs), and auras ap-
peared either independently or at the beginning of the seizure
in six of them. CPS occasionally led to secondary generaliza-
tion in four patients.
1784 Acta Neurochir (2015) 157:1783–1792
Each patient underwent a routine presurgical examination
[neurologic and neuropsychological testing, repeated
interictal electroencephalography (EEG), scalp video-EEG
study with ictal recording, magnetic resonance imaging
(MRI) and intracarotid Amytal test].
In addition to a standard scalp 10–20-electrode system,
sphenoidal electrodes were used for the interictal video-EEG
evaluation in two patients (patients 1, 2). Foramen ovale elec-
trodes for ictal recording were inserted in seven patients (pa-
tients 2, 4–9). In one patient (patient 9) noninvasive data were
inconclusive, and an invasive study was performed with a
combination of strip and depth electrodes. A similar electrode
combination was also used in patient 1, as temporal lobe at-
rophy found on MRI did not exclude neocortical temporal
lobe epilepsy.
The MRI study included a T1-weighted three-dimensional
acquisition, a tilted coronary T2-weighted acquisition with a
long second echo, and fluid-attenuated inversion-recovery se-
quences. Unilateral MTLE was diagnosed in all patients.
The patients underwent GKRS targeted to the medial tem-
poral lobe (to the amygdala, sparing the superior and mesial
part, to the head and anterior half of the body of hippocampus,
and to the anterior part of the parahippocampal gyrus). The
radiosurgical parameters for six of our patients (patients 2, 4–
8) were the same as those described by Rėgis et al. [25].
Prominent radiation-induced responses led us to reduce the
dose and volume in patients 3 and 9–14. The mean irradiated
volume for the whole group was 6.764 mm3. In patients treat-
ed with 18–20Gy, it was 6.388 mm3 on average (ranging from
5.200 to 8.900), whereas in those irradiated with 25 Gy, the
average volume was 7.267 mm3 (6.600–7.700).
We offered all our patients the option of open surgery, and
five of them refused. In the remaining nine patients, an ante-
rior temporal lobectomy was performed on the side treated by
radiosurgery because of insufficient seizure control. No sur-
gery was indicated for any of the patients for either early or
late complications.
Mean follow-up was 191.5 months (median 190.5 months,
range 175–217). Operated patients were monitored for a mean
98.4 months (median 83, range 61–198) before the operation
and 93.2 months (median 102, range 12–153) after the oper-
ation. Unoperated patients were followed up for a mean
191.2 months (median 181, range 175–217).
Methods
A certified epileptologist reviewed seizure outcome and clas-
sified both operated and unoperated patients according to
Engel’s classification after GKRS, before the operation and
at the last check-up. As the effect of GKRS is delayed and
the patients’ seizure status may change over time, wemodified
the original Engel classification and presented outcome fig-
ures are calculated from seizure outcomes 2 years prior the
visit. A certified neuroradiologist reviewed follow-up MRI
scans and searched for signs of delayed complications. An
experienced neuropathologist re-examined the available his-
tological material from operated patients. This study was ap-
proved by the hospital Ethics Committee.
MRI
During the first 2 years after GKRS, patients followed a stan-
dard 3-monthly schedule for MRI follow-up controls. MRI
evaluations were performed on a 1.5-T whole-body MR sys-
tem (Magnetom, Siemens) according to the following proto-
col: TSE T2/PD WI axial, T2 WI turbo FLAIR axial, TSE T2
WI coronal, SE T1WI coronal plane, and SE T1WI coronal
and axial planes after application of gadolinium intravenous
contrast agents. Subsequently, for up to 4 years after GKRS,
MRI follow-ups were indicated according to the patients’ clin-
ical status, but at least once a year. Patients indicated for re-
operation by anteromesial temporal lobectomy (AMTL)
underwent a preoperative three-dimensional volume acquisi-
tion sequence (FLASH 3d) after administration of intravenous
gadolinium contrast agents. Other MRI evaluations were in-
constant and were dependent on the patients’ clinical status.
All patients were scheduled for late MRI follow-up 16–
18 years after GKRS. The late MRI follow-ups were per-
formed on a 3-T whole-body MRI system (Skyra, Siemens)
following the standard protocol in common diagnostic se-
quences: T2 3D, T2 WI turbo FLAIR axial and coronal,
TSE T2 WI coronal (coronal planes were orientated perpen-
dicular to the long axis of the hippocampus), SE T1 WI sag-
ittal, SWI 3D axial, DWI axial and SE T1WI coronal and axial
planes after administration of gadolinium intravenous contrast
agents.
Histological evaluation
In all cases material was examined by microscope in sections
from formaldehyde-fixed and paraffin-embedded blocks. Sec-
tions (4 μm thick) were stained using routine methods
(hematoxyline-eosin, periodic acid-Schiff (PAS), Masson’s
t r i ch rome) . Se l ec t ed s l i de s were examined by
imunohistochemistry using monoclonal antibodies—map2c
(DAKO), CD 68 (DAKO), p53 (DAKO), S100protein
(DAKO), GFAP (DAKO) and KI67 (DAKO).
Results
Seizure outcome
At the time our first patients underwent AMTL (39 months), 1
patient was Engel IIA, seven were IIIA, five were IVB and
one Engel IVC. Of nine operated patients, two were Engel
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IIIA, one was IVA, five were IVB and one Engel IVC before
the operation. At their last visit, they had become Engel class
IA in five cases, one patient was ID and two IIC. In one patient
(patient 2) the follow-up was not sufficiently long to justify
classification. Of the five unoperated patients, one was Engel
class IB, one IIIA, one IIB and one IVB at their last visit.
There was one death unrelated to epilepsy as a seizure-free
patient (patient 4) died from influenza 127 months after
AMTL.
MRI results
In the group as a whole, our short-term evaluation found edema
identified as a T2-weighted hyperintensity around a T1
contrast-enhancing volume in 11 patients. Collateral edema
reached outside the temporal lobe in six patients (Fig. 1). It
caused uncal herniation in two patients and intracranial hyper-
tension in three. We classifed these findings as radionecrosis.
This classification is supported by the fact that in 9 of these 11
patients postnecrotic pseudocysts developed during follow-up.
On longer term follow-up, postcontrast enhancement
persisted for 2.5–16 years after GKRS in all 14 patients, and
in 5 of these we detected its progression between 2 and
16 years after treatment (Fig. 2). In six patients we noted
permanent collateral damage outside the target structures with
gliosis of the white matter, in two patients signs of
neoangiogenesis were found, and in five microbleeds could
be seen (Fig. 3). Postoperative ischemia developed in four
patients in areas where edema had been identified earlier. In
two patients an optic tract lesion was present.
We investigatedwhether radiation doses and volumes treat-
ed influenced either the early or late complication rate. For this
purpose we divided patients into lower (18–20 Gy) and higher
(25 Gy) dose groups (Table 1). As mentioned above, lower
doses were targeted to somewhat smaller volumes.
In all patients treated with 25 Gy to the 50 % isodose (n=
6), radionecrosis developed 9–14 months after GKRS. En-
hancement was found to roughly correspond to the 50 % iso-
dose line. Collateral edema was confined to the temporal lobe
in two patients (patients 4 and 8). In the remaining four pa-
tients it reached outside the temporal lobe, both dorsally (oc-
cipital lobe) and medially (basal ganglia, internal capsule,
thalamus). In two patients it caused midline shift (patients 2
and 5) and in two cases uncal herniation (patients 2 and 6).
Clinical symptoms of intracranial hypertension appeared in
patients 6 and 7 and required hospitalization and intravenous
corticosteroid therapy.
During follow-up, postnecrotic pseudocysts developed in
all six patients. Postcontrast enhancement also persisted for 3–
9 years after GKRS in all patients. We found progression of
postcontrast enhancement between 8 and 16 years after GKRS
in patient 2, between 3 and 15 years in patient 6 and between 2
and 3.5 years in patient 8. In patient 4 postcontrast enhance-
ment in the target structures persisted until open surgery,
which was performed 39 months after GKRS. Prominent
gliosis outside the target structures was present in patients 2,
5 and 6. Signs of optic tract degeneration were evident in
patients 6 and 7. Notably, in both these patients intracranial
hypertension should be treated by intravenous corticosteroids.
In patient 6 edema gradually developed into the optic tract
lesion, which was apparent from 16 months after GKRS and
caused quadrant anopia. In patient 7 a small optic tract lesion
was evident 8 years after GKRS, but no gross visual field
defects were evident on neurological evaluation.
Microbleeding was present in patients 2, 5 and 6. After a
subsequent operation ischemia developed in patient 2 (in the
temporo-occipital region and thalamus) and caused
hemianopia. In patient 7 (internal capsule and thalamus) it
was clinically silent. Notably, both these complications were
found in patients in whom collateral edema had reached out-
side the temporal lobe. It seems that edema in the early de-
layed phase makes the areas where it occurs more vulnerable
to ischemia later.
The degree of radiologic changes in the lower-dose sub-
group (n=8) was somewhat more variable. Formation of
Fig. 1 a Peripheral ring enhancement 2 months after GKRS in patient 2.
b Large perifocal edema reaching outside the temporal lobe and midline
shift developed 11 months after GKRS in the same patient
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radionecrosis was delayed by 12–24 months and developed in
both patients treated with 20 Gy. In patient 1 it reached outside
the target structures to the temporopolar region. However,
radionecrosis was found to develop even in patients treated
Fig. 2 Postgadolinium contrast
enhancement (SE T1 transversal)
of postradiation changes in the
medial part of the left temporal
lobe; progression through years (a
row 7 years, b row 10 years, c row
15 years after therapy) found in
patient 14
Fig. 3 aWhite matter changes
after radiosurgery of the left
mesial temporal structures
15 years after therapy (TSE T2
coronal scans perpendicular to the
long axis of the hippocampus) in
patient 13 (arrowheads). b The
angioproliferative nodule
15 years after treatment in patient
11 (right picture, TSE T2 coronal;
middle picture, FLAIR coronal;




16 years after GKRS in patient 11
(arrowheads)
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by 18 Gy (patients 10 and 11). Collateral edema reaching
outside the temporal lobe only formed in those treated with
20 Gy (patients 1 and 3), and in one of them (patient 3) it
caused a midline shift with signs of intracranial hypertension
requiring oral corticosteroids. Interestingly, this patient was
also treated by insulin for diabetes. Diabetes is identified as
a possible predisposing factor for the development of
radionecrosis [24]. In another patient (patient 1) large
radionecrosis and collateral edema did not cause clinically
manifest intracranial hypertension, presumably because of
preexisting ipsilateral temporal lobe atrophy. In the remaining
patients in whom radionecrosis did not develop (patients 9, 11,
12, 13), the most frequent finding was small edema and en-
hancement of target structures, which occurred 11–36 months
after GKRS.
Postcontrast enhancement persisted for up to 4–7 years. Pro-
gression of this enhancement was noted in patients 9, 10 and 14
beginning 5 years after GKRS and lasting until surgery and
between 3–16 years and 4–15 years after GKRS, respectively.
Gliosis outside the target structures was noted in patients 1, 9,
11 and 14. Signs of microbleeding were present in patients 11
and 14. Postoperative ischemia was found in patient 3.
Histopathological evaluation
Unfortunately, histology specimens were only available for
revision in seven patients (2, 3, 6, 7, 9, 12, 13). Microscopi-
cally, we found late postradiosurgery effects in all cases. In
patients 2, 9 and 12 thickened walls of blood vessels with
obliterated lumens and necrosis were observed in the
parahippocampal gyrus and hippocampus. Proliferation of
the blood vessels and evidence of recanalization mimicked
AVM (Fig. 4). In patient 6 fibrinoid necrosis, gliosis and slight
angiogenesis were observed. In patients 3, 7 and 13 only
gliotic changes were found. The surrounding gliotic tissue
can be focally calcified. In other biopsy specimens we found
reactive gliosis with pseudocysts of various sizes and with
macrophage infiltration (Fig. 5). Similar changes along with
Table 1 Early and late MRI changes in treated patients
Case Early delayed changes Late delayed changes
1 RE (18 m; 40×30×30 mm), EOTL PNPC, GOTS, PCE (2.5 years)
2 RE (11 m; 40×30×30 mm), EOTL, UH, MS, PNPC, GOTS, PCE (8 years), PPCE (8–16 years), MB, NAG, POI (TO, Th)- HA
3 RE (12 m, 40×25×2 5 mm), EOTL, MS PNPC, PCE (6 years), POI
4 RE (11 m; 32×22×20 mm) PNPC, PCE (3 years)
5 RE (12 m; 55×30×36 mm), EOTS (BG, TO), MS PNPC, GOTS, PCE (17 years), MB
6 RE (14 m; 43×37×27 mm), EOTL, UH PNPC, PCE (3 years), PPCE (3–12 years), GOTS (TO), MB, OTL (16 m), QA
7 RE (9 m; 31×26×20 mm), EOTL (CE, CI, BG, Th) PNPC, PCE (8 years), OTL, POI (CI, Th)
8 RE (18 m; 20×10×10 mm), TLE PNPC, PCE (2 years), PPCE (2–3.5 years)
9 ETS, TLE PCE (16 years), POI
10 RE (24 m; 30×18×10 mm), TLE PNPC, PCE (16 years), MB
11 RE (36 m; 12×11×18 mm), TLE PNPC, GOTS, PCE (16 years), MB, NAG (16 years)
12 ETS PCE (4 years)
13 ETS (8×7×5 mm) GOTS, PCE (5 years), PPCE (5–8 years)
14 RE (18 m; 20×25×15 mm), TLE PCE (4 years), PPCE (4–15 years), MB
Lower- and higher-dose subgroup results are highlighted with blue and red color, respectively
Abbreviations: BG basal ganglia, CI internal capsule, EOTL expansive edema outside the temporal lobe, ETS enhancement and edema of target
structures, GOTS gliotic changes outside target structures, HA hemianopia, MB microbleeding, MS midline shift, NAG neoangiogenesis, OTL optic
tract lesion, PCE persisting postcontrast enhancement, PNPC postnecrotic pseudocyst, POI postoperative ischemia, PPCE progression of enhancement
(duration in years in brackets),QA quadrantanopia, RE ring enhancement, SETS small enhancement of target structures, Th thalamus, TLE temporal lobe
edema, TO temporo-occipital region, TP temporal pole, UH uncal herniation
Fig. 4 Angiomatous proliferation with partially obstructed and
recanalized blood vessels 16 years after GKRS in patient 2
(hematoxilin-eosin, magnification 40×)
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perioperative damage were described in both discarded
specimens.
Discussion
The use of GKRS for intractable MTLE began in the mid
1990s. Various seizure outcomes have been reported in the
literature since that time. In our group of 14 patients none
became entirely seizure-free after the treatment. One patient
from the lower-dose subgroup was Engel IB at her last visit.
Of the patients who underwent subsequent operations, a
seizure-free outcome was achieved in five of eight patients.
Marginal doses of 20–25 Gy to the 50 % isodose were
reported to be effective for seizure control. These doses usu-
ally cause destructive reactions in the targeted structures and
collateral edema [17]. These well-known complications could
cause transient seizure worsening, intracranial hypertension
and a delayed effect of GKRS. These alterations occurred
approximately 9–12 months after the treatment and gradually
changed into nonhomogeneous atrophy in the target area by
the end of the second year. They are thought to be required for
successful seizure control [4].
Radiation injury is related to numerous factors, of which
dose and volume are paramount [18]. However, the degree of
radiographic changes is extremely variable and unpredictable
[29]. It is influenced by the type of tissue treated and location
of the lesion. Individual sensitivities to radiation injurymay be
affected by genetic factors (e.g., DNA repair mechanisms) or
even acquired conditions, such as intracranial atherosclerosis.
It is widely accepted that normal brain tissue (as is the case in
most cases of HS) is more vulnerable to radiation injury than
brain tumors [13].
In our group of patients, radionecrosis and collateral edema
were more likely to occur and developed earlier in those
treated with higher doses. In a lower dose subgroup various
degrees of tissue destruction could be seen onMRI in patients
treated with similar protocols. Intracranial hypertension may
develop in vulnerable patients treated with lower doses. We
reported on the functional consequences (worsening seizure
frequency, headaches) in our previous work [37]. Some au-
thors advocate the view that collateral damage is reversible
and does not affect seizure control later on [27]. These chang-
es were thought to constitute a fair trade-off in terms of the
greater comfort for the patients and the minimally invasive
nature of GKRS. In our material, however, we found exten-
sive collateral damage (temporal lobe white matter, optic
tract). These morphological alterations occur in patients treat-
ed by both lower and higher doses and can have functional
consequencies (e.g., visual field defects).
Delayed radiation necrosis and cyst formation (incidence
2–30 %) were described after GKRS for various conditions.
They can occur many years after treatment. Finet et al. were
the first to report the case of a patient treated with GKRS for
MTLE who developed intracranial hypertension because of a
hemorrhagic lesion in the treated area with temporal conus
requiring urgent surgery 6 years after GKRS [9]. Ganz and
Reda described a man who developed similar changes identi-
fied by MRI, refused surgery and became blind because of
remote radionecrosis [13]. Vale et al. referred to the case of a
patient with early edema requiring corticosteroid treatment in
whom late seizure recurrence occurred because of the forma-
tion of an enhancing cystic lesion in the mesial temporal lobe
[36]. Usami et al. decribed a series of seven patients treated by
18–25 Gy to the 50 % isodose [35]. High-dose treatment was
effective in abolishing seizures in two of five patients and
significantly reduced seizure frequency in two others, but re-
quired open surgery because of symptomatic radionecrosis 5–
10 years after treatment in two patients. In one patient who
was not operated on, MRI showed radionecrosis 10 years after
treatment. Kawamura et al. reported 11 patients, only 1 of
whom was seizure-free and without symptomatic complica-
tions during long-term follow-up [18]. However, even in this
patient, extensive radiation-induced changes could be seen on
MRI. Chen et al. reported on four patients (2 of them with
MTLE), one of whom was Engel class IA, two of whom were
unchanged (IVA) and one with worsened seizures (IVC) [6].
In all patients subsequent resection was performed for
radionecrosis, which developed 7–12 years after the
radiosurgical treatment. All the patients were Engel class I (3
patients I A and 1 patient I B) after the operation. Histologic
examination in operated cases revealed lesions of the gray and
white matter consisting of necrosis, neuronal loss and
astrogliosis, and vascular changes with hyalinization, neovas-
cularization, hemorrhagic foci and hemosiderin depositions.
The most common theory attributes the development of
late radionecrosis and cyst formation to endothelial cell dam-
age with progressive dysfunction of the blood-brain barrier
Fig. 5 Perivascular macrophage infiltration (patient 3) 6 years after
GKRS (CD 68, magnification 100×)
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[7]. Fibrinoid necrosis of blood vessel walls occurs first,
followed by vessel wall thickening, hyalinization and telangi-
ectasia. An influx of leukocytes leads to the overproduction of
various cytokines, inducing oligodendrocyte apoptosis. Leak-
age of serum components into the brain tissue causes glial
injury and fibrinoid coagulative degeneration with subsequent
cyst formation. The development of delayed complications
was suggested by the emergence of microbleeding,
postcontrast enhancement and perifocal edema [30].
However, in our material we found some kinds of these
signs, usually in combination, in every patient. Therefore, it
follows that radiation-induced changes are still active many
years after therapy. These morphological alterations may de-
velop into more serious complications (late necrosis, degener-
ative angiomatosis) many years after treatment with signifi-
cant negative functional, even life-threatening, consequences.
Thus, any patient treated with GKRS for MTLE should be
regularly screened for late complications. These facts should
be taken into account when planning future studies of this
method. This information could be of interest for physicians
who refer their patients for this treatment.
Our study has many limitations: (1) The group of patients is
small and inhomogeneous as treatment protocols vary. (2)
There is no control group of patients treated by standard epi-
lepsy surgery methods. However, it is hardly possible to have
a control group for a historical case series. Historically, radio-
surgery was used in a limited number of institutions. There-
fore, long-term follow-up results are limited and thus valu-
able. (3) Histological specimens were not available for re-
analysis in all patients. (4) It shows a single-center experience.
(5) It is a retrospective study. However, its aim is not to give a
comprehensive evidence-based account.
Conclusion
The role of GKRS in the treatment of epilepsy is still unclear,
although at present pharmacoresistant MTLE is a treatable
condition. Microsurgery is a safe treatment that can achieve
control of seizures immediately after surgery with the advan-
tage that a histological diagnosis is obtained. After GKRS,
there is a delay in antiseizure effects that carries a risk of
mortality because of accidents and the possibility of sudden
unexplained death in epilepsy. It seems that edema in the early
delayed phase makes the areas where it occurs more vulnera-
ble to ischemia during subsequent operations. GKRS for
MTLE could cause serious late complications caused by vas-
cular and inflamatory mechanisms. These changes may even
occur in patients treated with lower doses. Our results stress
the need for life-long MRI follow-up. These facts should be
taken into account when planning future studies of this
method.
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Comment
The radiosurgical treatment of MTLE is being discussed based on the
prerequisites of a presumed sufficient efficacy, low complication risk
and superior neuropsychological outcome. The current article contributes
relevant outcome data based on a longmedian follow-up of 190.5months.
Although not stratified by specified cohorts, the current description of the
outcome contributes relevant information to the ongoing discussion, in
particular with respect to the response rate and side effects of the
radiosurgical intervention. The conclusion that patients treated with
GKRS for MTLE should be regularly screened for late complications is
essential for clinical practice. Even when the target, dose and volume can
potentially be discussed and optimised in the future, the article reflects
actual clinical practice in an innovative field of radiosurgery and cautious-
ly but substantially questions the clinical safety of the method.
Bodo Lippitz
London, UK
In the present article Vojtĕch et al. report their long-term experience in
the treatment of patients suffering from medial temporal lobe epilepsy
with Gamma Knife radiosurgery (GKRS) in a single center. They con-
cluded that GKRS carries several risks including potential neurologic
damaging comparable to those after surgical resection, the possibility of
sudden onset death in epilepsy due to a delay in antiseizure effects, and
late complications due to vascular and inflammatory mechanisms caused
by radiation. Additionally, the outcome concerning a decrease of seizures
after GKRS did not reveal antiseizure efficacy.
The article is clearly structured and deals with a very interesting—and
important—topic. Limitations, possible complications and risk factors of
the evaluated technique are emphasized and are easy to understand also
for readers who do not treat these patients regularly. There are some
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limitations of the study due to its retrospective design, small group of
patients and lack of a control group.
Nevertheless, in the reviewer’s opinion the subject of treating a
condition with radiation that has been treated surgically for decades
with good success is of great importance. In the past years, an
increasing number of Bnontumorous^ pathologies in an increasing
number of young patients have been treated with radiosurgery. Com-
pared to surgical resection, often the less destructive character and
the lack of risk of perioperative morbitidy and mortality in patients
who are treated with radiosurgery are accentuated. But it is of im-
portance to keep in mind that radiosurgery has the potential to in-
duce histomorphological changes for decades to come, as stated in
the ‘Discussion.’ Apart from that, neurological deterioration—after
some time—is commonly seen following radiation. As emphasized
in the article, these risks have to be considered if future studies
concerning GKRS are planned.
Joachim Oertel, Doerthe Keiner
Homburg Saar, Germany
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